Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer

Immunotherapy has offered a new opportunity for the treatment of many malignancies. In patients with lung cancer, immune checkpoint inhibitors have significantly improved survival. However, little is known about predictive factors or primary and acquired resistance mechanisms. Epithelial-to-mesenchy...

Descripción completa

Detalles Bibliográficos
Autores principales: De Matteis, Serena, Canale, Matteo, Verlicchi, Alberto, Bronte, Giuseppe, Delmonte, Angelo, Crinò, Lucio, Martinelli, Giovanni, Ulivi, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721259/
https://www.ncbi.nlm.nih.gov/pubmed/31531020
http://dx.doi.org/10.1155/2019/7475364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721259/
https://www.ncbi.nlm.nih.gov/pubmed/31531020
http://dx.doi.org/10.1155/2019/7475364

Ejemplares similares